P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE INHIBITOR ENTINOSTAT + PEMBROLIZUMAB IN MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA REFRACTORY TO HYPOMETHYLATING AGENTS

• Jan Bewersdorf,
• Rory M. Shallis,
• Elad Sharon,
• Anne Caldwell,
• Wei Wei,
• Abdulraheem Yacoub,
• Yazan Madanat,
• Joshua Zeidner,
• Jessica Altman,
• Olatoyosi Odenike,
• Swaroopa Yerrabothala,
• Tibor Kovacsovics,
• Nikolai Podoltsev,
• Stephanie Halene,
• Richard Little,
• Richard Pierkarz,
• Steven Gore,
• Tae Kon Kim,
• Amer M. Zeidan

Affiliations

Jan Bewersdorf

1 Memorial Sloan Kettering Cancer Center New York, Leukemia Service, New York, United States

Rory M. Shallis

2 Yale School of Medicine, New Haven, United States

Elad Sharon

3 National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, United States

Anne Caldwell

2 Yale School of Medicine, New Haven, United States

Wei Wei

2 Yale School of Medicine, New Haven, United States

Abdulraheem Yacoub

4 The University Of Kansas Medical Center, Kansas City, United States

Yazan Madanat

5 UT Southwestern Medical Center: Hematology/Oncology, Dallas, United States

Joshua Zeidner

6 UNC Lineberger Comprehensive Cancer Center, Chapel Hill, United States

Jessica Altman

7 Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, United States

Olatoyosi Odenike

8 UChicago Medicine, Chicago, United States

Swaroopa Yerrabothala

9 Dartmouth Hitchcock Medical Center, Lebanon, United States

Tibor Kovacsovics

10 Huntsman Cancer Center, Salt Lake City, United States

Nikolai Podoltsev

2 Yale School of Medicine, New Haven, United States

Stephanie Halene

2 Yale School of Medicine, New Haven, United States

Richard Little

3 National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, United States

Richard Pierkarz

3 National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, United States

Steven Gore

3 National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, United States

Tae Kon Kim

11 Vanderbilt-Ingram Cancer Center, Nashville, United States

Amer M. Zeidan

2 Yale School of Medicine, New Haven, United States